Efficacy and safety of carfilzomib in patients with relapsed/refractory multiple myeloma in the real world: meta-analysis of single proportions

Li Yun, Li Bingsheng, Li Yixiu, Yuan Zhen, Xiong Aizhen

PDF(1303 KB)
PDF(1303 KB)
Adverse Drug Reactions Journal ›› 2024, Vol. 26 ›› Issue (3) : 162-169. DOI: 10.3760/cma.j.cn114015-20230714-00526

Efficacy and safety of carfilzomib in patients with relapsed/refractory multiple myeloma in the real world: meta-analysis of single proportions

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2024, 26(3): 162-169 https://doi.org/10.3760/cma.j.cn114015-20230714-00526

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1303 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉